• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沃纳综合征解旋酶/核酸外切酶(WRN)在体外可破坏并降解D环。

The Werner syndrome helicase/exonuclease (WRN) disrupts and degrades D-loops in vitro.

作者信息

Orren David K, Theodore Shaji, Machwe Amrita

机构信息

Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky 40536, USA.

出版信息

Biochemistry. 2002 Nov 19;41(46):13483-8. doi: 10.1021/bi0266986.

DOI:10.1021/bi0266986
PMID:12427008
Abstract

The loss of function of WRN, a DNA helicase and exonuclease, causes the premature aging disease Werner syndrome. A hallmark feature of cells lacking WRN is genomic instability typified by elevated illegitimate recombination events and accelerated loss of telomeric sequences. In this study, the activities of WRN were examined on a displacement loop (D-loop) DNA substrate that mimics an intermediate formed during the strand invasion step of many recombinational processes. Our results indicate that this model substrate is specifically bound by WRN and efficiently disrupted by its helicase activity. In addition, the 3' end of the inserted strand of this D-loop structure is readily attacked by the 3'-->5' exonuclease function of WRN. These results indicate that D-loop structures are favored sites for WRN action. Thus, WRN may participate in DNA metabolic processes that utilize these structures, such as recombination and telomere maintenance pathways.

摘要

WRN是一种DNA解旋酶和核酸外切酶,其功能丧失会导致早衰疾病——沃纳综合征。缺乏WRN的细胞的一个标志性特征是基因组不稳定,其典型表现为非法重组事件增加以及端粒序列加速丢失。在本研究中,我们在一个替代环(D环)DNA底物上检测了WRN的活性,该底物模拟了许多重组过程的链侵入步骤中形成的中间体。我们的结果表明,这种模型底物能被WRN特异性结合,并被其解旋酶活性有效破坏。此外,该D环结构插入链的3'端很容易受到WRN的3'→5'核酸外切酶功能的攻击。这些结果表明,D环结构是WRN发挥作用的有利位点。因此,WRN可能参与利用这些结构的DNA代谢过程,如重组和端粒维持途径。

相似文献

1
The Werner syndrome helicase/exonuclease (WRN) disrupts and degrades D-loops in vitro.沃纳综合征解旋酶/核酸外切酶(WRN)在体外可破坏并降解D环。
Biochemistry. 2002 Nov 19;41(46):13483-8. doi: 10.1021/bi0266986.
2
Coordinate action of the helicase and 3' to 5' exonuclease of Werner syndrome protein.沃纳综合征蛋白的解旋酶与3'至5'核酸外切酶的协同作用。
J Biol Chem. 2001 Nov 30;276(48):44677-87. doi: 10.1074/jbc.M107548200. Epub 2001 Sep 25.
3
DNase I footprinting and enhanced exonuclease function of the bipartite Werner syndrome protein (WRN) bound to partially melted duplex DNA.与部分解链的双链DNA结合的二分体沃纳综合征蛋白(WRN)的DNA酶I足迹分析及增强的核酸外切酶功能
J Biol Chem. 2002 Feb 8;277(6):4492-504. doi: 10.1074/jbc.M108880200. Epub 2001 Nov 20.
4
Werner syndrome protein. I. DNA helicase and dna exonuclease reside on the same polypeptide.维尔纳综合征蛋白。I. DNA解旋酶和DNA外切核酸酶存在于同一条多肽链上。
J Biol Chem. 1998 Dec 18;273(51):34139-44. doi: 10.1074/jbc.273.51.34139.
5
Werner syndrome exonuclease catalyzes structure-dependent degradation of DNA.沃纳综合征核酸外切酶催化依赖结构的DNA降解。
Nucleic Acids Res. 2000 Sep 1;28(17):3260-8. doi: 10.1093/nar/28.17.3260.
6
The Werner syndrome helicase/exonuclease processes mobile D-loops through branch migration and degradation.沃纳综合征解旋酶/核酸外切酶通过分支迁移和降解处理移动性D环。
PLoS One. 2009;4(3):e4825. doi: 10.1371/journal.pone.0004825. Epub 2009 Mar 13.
7
TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA.端粒重复结合因子2招募沃纳综合征(WRN)核酸外切酶来处理端粒DNA。
Oncogene. 2004 Jan 8;23(1):149-56. doi: 10.1038/sj.onc.1206906.
8
Competition between the DNA unwinding and strand pairing activities of the Werner and Bloom syndrome proteins.维纳综合征和布卢姆综合征蛋白的DNA解旋与链配对活性之间的竞争。
BMC Mol Biol. 2006 Jan 13;7:1. doi: 10.1186/1471-2199-7-1.
9
Nuclear DNA helicase II (RNA helicase A) interacts with Werner syndrome helicase and stimulates its exonuclease activity.核DNA解旋酶II(RNA解旋酶A)与沃纳综合征解旋酶相互作用并刺激其核酸外切酶活性。
J Biol Chem. 2005 Sep 2;280(35):31303-13. doi: 10.1074/jbc.M503882200. Epub 2005 Jul 1.
10
The Werner syndrome helicase and exonuclease cooperate to resolve telomeric D loops in a manner regulated by TRF1 and TRF2.沃纳综合征解旋酶和核酸外切酶协同作用,以TRF1和TRF2调控的方式解开端粒D环。
Mol Cell. 2004 Jun 18;14(6):763-74. doi: 10.1016/j.molcel.2004.05.023.

引用本文的文献

1
Therapeutic targeting of mismatch repair-deficient cancers.错配修复缺陷型癌症的治疗靶向作用
Nat Rev Clin Oncol. 2025 Jul 10. doi: 10.1038/s41571-025-01054-6.
2
During recombinase-mediated homology recognition RecQ helicases inhibit formation of toxic long-lived D-loops that could promote genomic instability.在重组酶介导的同源识别过程中,RecQ解旋酶抑制可能促进基因组不稳定的有毒长寿命D环的形成。
Nucleic Acids Res. 2025 May 10;53(9). doi: 10.1093/nar/gkaf426.
3
Response to Replication Stress and Maintenance of Genome Stability by WRN, the Werner Syndrome Protein.
WRN,即 Werner 综合征蛋白,对复制压力的响应和基因组稳定性的维持。
Int J Mol Sci. 2024 Jul 30;25(15):8300. doi: 10.3390/ijms25158300.
4
Large-scale expansions of Friedreich's ataxia GAA•TTC repeats in an experimental human system: role of DNA replication and prevention by LNA-DNA oligonucleotides and PNA oligomers.在实验性人类系统中,弗里德里希共济失调 GAA•TTC 重复序列的大规模扩增:DNA 复制的作用以及 LNA-DNA 寡核苷酸和 PNA 寡聚物的预防作用。
Nucleic Acids Res. 2023 Sep 8;51(16):8532-8549. doi: 10.1093/nar/gkad441.
5
A non-catalytic N-terminus domain of WRN prevents mitotic telomere deprotection.WRN 的非催化 N 端结构域防止有丝分裂中端粒去保护。
Sci Rep. 2023 Jan 12;13(1):645. doi: 10.1038/s41598-023-27598-0.
6
Clinical prospects of WRN inhibition as a treatment for MSI tumours.WRN抑制作为微卫星高度不稳定(MSI)肿瘤治疗方法的临床前景。
NPJ Precis Oncol. 2022 Nov 15;6(1):85. doi: 10.1038/s41698-022-00319-y.
7
The Regulation of Homologous Recombination by Helicases.解旋酶对同源重组的调控。
Genes (Basel). 2020 May 1;11(5):498. doi: 10.3390/genes11050498.
8
Werner Syndrome Protein and DNA Replication. Werner 综合征蛋白与 DNA 复制。
Int J Mol Sci. 2018 Nov 2;19(11):3442. doi: 10.3390/ijms19113442.
9
RecQ and Fe-S helicases have unique roles in DNA metabolism dictated by their unwinding directionality, substrate specificity, and protein interactions.RecQ 和 Fe-S 解旋酶在 DNA 代谢中具有独特的作用,这取决于它们的解旋方向、底物特异性和蛋白相互作用。
Biochem Soc Trans. 2018 Feb 19;46(1):77-95. doi: 10.1042/BST20170044. Epub 2017 Dec 22.
10
Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome.p38丝裂原活化蛋白激酶抑制剂用于治疗沃纳综合征
Pharmaceuticals (Basel). 2010 Jun 4;3(6):1842-1872. doi: 10.3390/ph3061842.